Ken Griffin Sol Gel Technologies Ltd. Call Options Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$0.37 - $0.96 $1,443 - $3,744	-3,900 Reduced 72.22%	1,500 $1,000
Q2 2024 Aug 14, 2024	BUY	$0.66 - $1.05 $3,432 - $5,460	5,200 Added 2600.0%	5,400 $4,000
Q1 2024 May 15, 2024	SELL	$0.95 - $1.5 $285 - $450	-300 Reduced 60.0%	200 $0
Q3 2023 Nov 14, 2023	SELL	$1.63 - $3.94 $488 - $1,182	-300 Reduced 37.5%	500 $0
Q2 2023 Aug 14, 2023	BUY	$2.99 - $4.15 $2,392 - $3,320	800 New	800 $2,000

5.35M

1.5K

Ticker SLGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,129,500
Market Cap $10.2M
Description
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.